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Although asbestos is a well-established lung carcinogen, there currently is no suitable human cell
model in which to examine the underlying cellular and molecular changes associated with fiber-
mediated bronchial carcinogenesis. Using a recently established transformation model based on a
human papillomavirus-immortalized human bronchial epithelial cell line, we successfully
transformed these BEP2D cells after a single, 7-day treatment with a 20-pg/ml (4 pg per cm2
area) dose of Union Internationale Contre le Cancer (UICC) Rhodesian chrysotile fibers. Asbestos
treatment resulted in a surviving fraction of 0.18 compared to control cells. Transformed cells
developed through a series of sequential steps, including altered growth kinetics, resistance to
serum-induced terminal differentiation, and anchorage-independent growth, before becoming
tumorigenic to form progressively growing tumors in nude mice. Seven tumorigenic cell lines
were isolated and determined to be of human epithelial origin based on immunofluorescent
staining of keratin and isozyme analysis. Analysis of tumor DNA revealed no mutations at either
codon 12 or 13 in any the ras oncogenes. An independent role for K-ras mutation in fiber
carcinogenesis, therefore, cannot be confirmed. This model provides a unique opportunity to
study the cellular and molecular changes at the various stages in fiber-mediated neoplastic
transformation of human bronchial epithelial cells. Environ Health Perspect 105(Suppl 5):
1085-1088 (1997)
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Introduction
Although asbestos is carcinogenic and
induces both bronchogenic carcinoma and
mesothelioma in man, the underlying
mechanisms offiber carcinogenesis are not
entirely clear at present. Various in vitroand
in vivostudies, however, have suggested that
fiber dimensions, surface properties, and
physical durability are important criteria for
the carcinogenicity of the fibers (1,2).
Studies using oncogenic transformation as
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an end point have shown that asbestos
fibers can induce morphologically trans-
formed foci in certain rodent cells (3). In
addition, a supra-additive oncogenic trans-
formation incidence has been demon-
strated in rodent cells treated with asbestos
fibers in combination with either ionizing
radiation or chemical carcinogen [for
review, see Hei (4)]. Recent evidence sug-
gests that oxygen radicals may be impor-
tant mediators in the toxicity, oncogenic
transforming potential, and genotoxicity of
asbestos fibers (2). Several studies have
shown that the iron present in many types
ofcarcinogenic fibers provides the neces-
sary catalyst in the formation of forming
reactive oxygen species through a series of
one-electron reductions ofmolecular oxygen
(5,6). The mutagenic effects ofasbestos in
mammalian cells have recently been demon-
strated using a model system that can
detect gross chromosomal deletions (4,7).
These findings provide the first direct link
between chromosomal abnormalities that
frequently occur in fiber-exposed human
and rodent cell lines and carcinogenicity
in vivo. The observation that antioxidant
enzymes such as catalase and superoxide
dismutase protect cells against the muta-
genic effects of asbestos provides further
evidence for the role ofoxyradicals in fiber
toxicology (8).
For a better understanding ofthe cellular
and molecular mechanisms involved in
human bronchial carcinogenesis by asbestos
fibers, it would be ideal to use a human
bronchial cell line that has been exposed to
asbestos to assess the various transformation
stages leading to malignancies. Until
recently, no human cell model has been
available for these studies because human
cells in culture are refractory to malignant
transformation in vitro (9). Recent studies
using a human papillomavirus-immortal-
ized human bronchial epithelial cell line
(BEP2D) have shown that malignant trans-
formation is induced by treatment with a
single, 30-cGy dose ofradon alpha particles
at a frequency estimated to be approxi-
mately 4x 10-7 after successive cultivation
for 3 to 4 months postirradiation (10,11).
In the present studies, we show that a sin-
gle, 7-day treatment with chrysotile fibers
induces malignant conversion of these
immortalized cells. Transformed cells
progress through sequential stages, includ-
ing altered growth kinetics, resistance to
serum-induced terminal differentiation,
and anchorage-independent growth, before
becoming tumorigenic and producing pro-
gressively growing subcutaneous tumors
upon inoculation into athymic nude mice.
Materials and Methods
clei Ccutur
The human papillomavirus (HPV18)
immortalized human bronchial epithelial
cell line at passages 21 and 22 was used in
these studies (12). These cells have near
diploid karyotype and have been in culture
for more than 200 population doublings.
They are anchorage dependent and non-
tumorigenic in nude mice. Cells were
routinely cultured in serum-free LHC-8
medium (Biofluid, Rockville, MD) supple-
mented with epidermal growth factor and
other growth supplements as described pre-
viously (10-12). Parental and tumorigenic
BEP2D cells were negative for Mycoplasma
contamination as determined by either
DNA fluorochrome staining or polymerase
chain reaction (PCR) amplification with
the Mycoplasma detection kit (American
Type Culture Collection, Rockville, MD).




Union Internationale Contre le Cancer
(UICC) standard reference Rhodesian
chrysotile fibers (average length, 7.8 p;
average diameter, 0.2 p) were used in the
study. The compositional analysis, size dis-
tribution, and preparation of the fibers
were described previously (4,7): Briefly,
chrysotile fibers were weighed, suspended
in distilled water, autoclaved to sterilize,
and used at the concentration indicated.
The fibers were dispersed by sonication
for 5 min before being diluted with tissue
culture medium for cell treatment.
Exponentially growing BEP2D cells rang-
ing in number from 3x 106 to 5x 106 cells
were treated with either a 10 or 20 pg/ml
dose of fibers for a period of7 days After
treatment, cells were trypsinized and resus-
pended in serum-free medium. Aliquots
were then plated into 60-mm diameter
dishes to determine clonogenic survival
and the remaining cells were replated
for transformation assays as described
previously (10,11).
AssayforTransformed Phenotypes
Alteration in growth kinetics, resistance to
serum-induced terminal differentiation,
anchorage-independent growth, and
tumorigenicity in nude mice were assayed
as described previously (10,11). The
epithelial origins of BEP2D cells and their
transformed variants were determined by
immunohistochemical staining ofkeratin.
Briefly, exponentially growing BEP2D cells
on glass chamber slides (Nunc, Inc.,
Naperville, IL) were washed and stained





(ICN Immunobiological, Lisle, IL) for
60 min at 370C. The slides were then rinsed
and counterstained with goat antimouse
IgG-FITC (Sigma Chemical Co, St. Louis,
MO) for 15 min at room temperature.
After washing, the slides were mounted in
buffered glycerol and examined under a
fluorescent microscope. To establish cul-
tures from either the primary or secondary
tumors, nodules were resected under asep-
tic conditions, minced into I-mm2 frag-
ments, and subjected to 0.1% collagenase
treatment (Sigma, Type IV) for 2 hr at
37°C as previously described (10). After
centrifugation at 200xg for 5 min, the
resulting pellets were trypsinized for 4 min
with 0.05% trypsin-EDTA solution
(GIBCO, Grand Island, NY). The cell sus-
pension was then centrifuged again before
resuspending in medium and plating out in
culture dishes. The viability ofcell suspen-
sion determined by trypan blue exclusion





Genomic DNA was amplified using
ras-specific oligonucliotides that were
slightly altered from the genomic sequences
to create primer-mediated restriction sites
that overlapped ras codons (13). A muta-
tion at the respective position was associ-
ated with the loss of a restriction enzyme
site, except for the aspartic acid mutation
at codon 13 ofthe K-ras, which resulted in
the gain ofa restriction site. High molecu-
lar weight DNA from the various tumori-
genic and transformed cell lines were
prepared using standard phenol chloro-
form extraction, as described previously
(7,10). The 5' primer used was ACT GAA
TAT AAA CTT GTG GTA GTT GGA
CCT, and the 3' primer sequence was TCA
AAG AAT GGT CCT GGA CC. For
codon 12, the endonuclease BstNl was
Table 1. Characterization ofchrysotile asbestos-treated BE
used, whereas Hph1 was used for codon 13
as previously described (11,13).
Results
BEP2D cells grow in culture as a contact-
inhibited monolayer with an epithelial
morphology. At confluency, they have
a saturation density of approximately
9.5 x 104 cells/cm2 of growth area. The
plating efficiency of the cell is between 15
and 25%, with an average population dou-
bling time of approximately 35 hr when
cultured in serum-free LHC medium
(10,11). Chrysotile asbestos induced a dose-
dependent decrease in the clonogenic sur-
vival of BEP2D cells (Figure 1). A single
treatment with a20-pg/ml dose offibers for
a period of7 days resulted in a survival frac-
tion of approximately 18% compared to
control cells. When fiber-exposed BEP2D
cells were subcultured and injected into
nude mice at this early stage, no tumor for-
mation was observed (Asb7Fc) (Table 1). It
was only with extensive subcultivation and
the accumulation ofadditional phenotypic/
mutagenic changes that tumorigenicity in
nude mice could be demonstrated.
Control cells stop cellular division and
undergo terminal differentiation in the
presence ofserum and the tumor promoter
12-O-tetradecanoylphorbol-13-acetate
(TPA) Figure 2. In the presence ofserum
and TPA, the normal plating efficiency of
BEP2D cells decreased to approximately
1% of the original value in serum-free
medium. In contrast, transformed cells
were much less responsive. There was no
difference in the colony growth for the
tumorigenic clone AsbTL cells whether or
not serum and TPA were present. In con-
trast, the anchorage-independent, non-
tumorigenic cell line, Asb7FA5, had a
colony-forming efficiency that was
approximately 70% of the control in the
presence ofboth serum and TPA (data not
shown). These data are consistent with the
previous observation that malignant
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Figure 1. Effects of graded doses of chrysotile
asbestos on clonogenic survival of BEP2D cells after a
single, 7-day treatment. The fiber concentration can be
converted to grams per square centimeter by dividing
the dose in grams per milliliter by 5. Each data point
represents pooled results from three experiments. Bars
represent ±SEM.
Dose, Time in culture, Growth in Cell line
Cell line pg/ml weeksa agarb Tumorigenicityc establishedd
Asb7Fc 20 2 - 0/3 -
Asb7 20 11 ++ 2/2 2
AsbTL 20 3 +++ 3/3 5
BEP2D 0 >22 - 0/37 -
aTime lapse between fiber treatment and testing for transformed phenotypes. bAnchorage-independent growth
ranged from approximately 0.25 to 0.8%. cNumber of animals with tumor divided by the total number of animals
injected. Each animal was injected at two different sites. A total of seven tumors were obtained from the five nude
mice. No tumor was formed in the three control animals or of a total of 37 mice tested, including historical controls.
dNumber of tumor cell lines established; isozyme analysis and keratin stain confirmed their human epithelial origin.
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AsbTL
Figure Clonal growth efficiency ofcontrol BEP2D cells
and the fiber-induced tumorigenic AsbTL cells in either
serum-free LHC medium or medium supplemented with
8% FBS and 100 ng/ml TPA (Midwest Research
Institute, Kansas City, MO). Bars represent ±SEM.
Figure 3. Representative immunofluorescent staining of human cytokeratin from AsbTL, a tumorigenic BEP2D cell
induced bychrysotile fibers. Note thatthe nuclei were counterstained with methyl green (magnification, x400).
epithelial cells are resistant to serum factors
that induce terminal differentiation in
normal epithefium (10,14).
Transformed and tumorigenic BEP2D
cells induced by chrysotile fibers were
tightly packed in culture. Although they
had similar growth kinetics when com-
pared with control cells, they routinely
showed a 2- to 3-fold higher saturation
density than the latter (10). Table 1 listed
the anchorage-independent and tumori-
genic characteristic ofcontrol cells and two
asbestos-induced tumorigenic cell lines.
Exponentially growing bronchial epithelial
cells treated with chrysotile fibers were sub-
cultured continuously for 11 weeks before
isolates ofagar-positive colonies emerged at
frequencies ranging from 0.25 to 0.8%.
Upon inoculation into nude mice, these
cells produced tumors with a latency
period of8 to 10 weeks at the site ofinjec-
tion. It should be noted that although
most agar-positive BEP2D clones were
nontumorigenic, they all demonstrated
the propensity to resist serum-induced ter-
minal differentiation. In contrast, the
majority of tumorigenic BEP2D cells
demonstrated anchorage-independent
growth, which illustrated the progressive
nature ofthe malignant phenotypes. When
the tumors had grown to a diameter of 1
cm, they were excised. Routine hema-
toxylin and eosin staining of paraffin-
embedded sections indicated that the
tumors were carcinoma in nature.
Immunohistochemical staining for
human cytokeratin indicated that the
tumor cells were of epithelial origin.
(Figure 3). The normal keratin expressed
in BEP2D cells was also expressed in
various transformed stages. In contrast,
normal fibroblasts that were used as nega-
tive controls in the staining procedure were
negative for keratin expression. It should
be noted that control cells subcultured
under identical conditions did not produce
any anchorage-independent clones. In
addition, none ofthe three animals injected
with the control cells together with 34
other historical controls produced tumors
up to 22 weeks postinoculation. Overall,
two primary tumorigenic cell lines were
established (Table 1). One of these lines,
AsbTL, was subsequently expanded in cul-
ture and reinoculated into nude mice. The
secondary tumors developed within a
shorter latency period of 2 to 3 weeks.
These studies show that chrysotile-treated
BEP2D cells undergo gradual, sequential
changes of altered growth and anchorage-
independent growth before becoming
tumorigenic in nude mice. In addition,
each preceding stage represents a necessary
but insufficient step toward the later, more
malignant phase.
Little information is available on
the functional role of oncogenes and
tumor-suppressor genes in fiber-mediated
bronchial carcinogenesis. Recent evidence
suggests that mutations in K-ras are fre-
quent in lung tumor specimens from
asbestos workers (15). However, most
patients in these studies were also smokers.
There is no evidence for the independent
role ofK-ras mutations in fiber carcinogen-
esis. Figure 4 shows the detection of K-ras
codon 13 mutations among the various
tumorigenic BEP2D cells induced by
asbestos fibers using a PCR-based restric-
tion enzyme-mediated assay. A mutation at
M 1 2 3 4 5 6
K-rascQdon 13
Figure 4. Detection of K-ras mutation at codon 13
using PCR amplification and restriction enzyme analy-
sis. (px 174 was used as a size marker (lane M). Lanes
1 and 2 are positive controls from HCT116 human colon
carcinoma cell lines. Mutations at codon 13 create the
recognition site for Hphl and cleave the fragments.
Lanes 3-6 are four representative tumorigenic BEP2D
cells induced by chrysotile fibers, and lane 7 is the
control BEP2D cells.
codon 13 resulted in the replacement of
glycine by aspartic acid and created the
Hphl recognition sequence GGTGA.
Normal fragments without the mutation
remained undigested, as shown by control
cells (Figure 4, lane 7), whereas DNA sam-
ples with mutations at codon 13, as shown
by the positive control HCT1 16 human
colon carcinoma cells, were digested
(Figure 4, lanes 1 and 2). None ofthe four
asbestos-induced tumorigenic cell lines
examined demonstrated mutations at
codon 13 of the K-ras (Figure 4, lanes
3-6). Similar negative results were
obtained at codon 12 of K-ras and at
codons 12 and 13 ofH-rasand N-ras (data
not shown).
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The mechanisms offiber carcinogenesis are
poorly understood. Asbestos induces chro-
mosomal aberrations, sister chromatid
exchanges, and multilocus deletions in
mammalian cells (2,7,8). In addition,
the human chromosomes frequently found
to be deleted in asbestos-associated meso-
theliomas, such as chromosomes 3p, 9p,
lIp, 13q, and 22q (16,17), are often asso-
ciated with genes with known tumor-sup-
pressor functions (17,18). The availability
of a human cell transformation model
based on bronchial epithelium in which
the malignant stage develops through a
series of sequential steps will provide a
unique opportunity to study the cellular
and molecular changes associated with
fiber-mediated carcinogenesis.
BEP2D cells constitute a suitable model
for the study ofthe various stages offiber-
induced human bronchial carcinogenesis.
These cells were initiated by lipofectin
transfection of cloned full-length HPV18
into normal human bronchial epithelial
cells obtained as outgrowths ofbronchial
explants (12). Although these bronchial
epithelial cells are immortal, they are
genotypically stable and express human
cytokeratin (10,11). They are anchorage
dependent and do not form tumors in
immunosuppressed host animals. The
observation that HPV-immortalized BEP2D
cells are nontumorigenic even in late
passages suggests that alterations in p53
and Rb functions are not sufficient criteria
for tumorigenic development and that
additional genetic changes are needed. The
finding that mutations in the Rb or p53
genes are not rate limiting for asbestos-
induced mesotheliomas (19) provides
further support for the suitability of
BEP2D cells in the study ofthe molecular
mechanisms offiber carcinogenesis.
Molecular epidemiologic studies have
shown that the incidence ofK-rasmutations
ranged from 30 to 60% among human
lung cancers. The highest incidence ofsuch
mutations has been reported by Husgafvel-
Pursianen et al. (15) in 60% of the cases
among asbestos miners, which indicates a
strong correlation between smoking and
asbestos exposure. Unfortunately, there is
no evidence for the independent role ofK-
rasmutations in fiber carcinogenesis. In the
present studies, none ofthe fiber-induced
tumorigenic cell lines showed mutations at
either codon 12 or 13 in any of the ras
oncogenes. These results are consistent with
our previous findings that most asbestos-
induced mutants are multilocus deletions
rather than point mutations (7,8). Our
results suggest that chemical carcinogens in
tobacco smoke such as benzo[a]pyrene and
the tobacco-specific nitrosamines may be
the likely inducers of K-ras mutations
among samples ofadenocarcinomas from
asbestos miners.
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